Repurposed drug improves outcomes for patients with severe COVID-19 pneumonia
17 July 2024
A drug used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could have further uses, according to clinical trial results from researchers at °×С½ãÂÛ̳, °×С½ãÂÛ̳H and the Francis Crick Institute including Professor Joanna Porter (°×С½ãÂÛ̳ Medicine).